These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35817697)
1. IgE-mediated anaphylaxis to methylprednisolone succinate in a patient with indolent systemic mastocytosis. Van Mieghem E; Beyens M; Van Gasse AL; Verlinden A; Ebo DG; Sabato V Allergol Int; 2022 Oct; 71(4):552-554. PubMed ID: 35817697 [No Abstract] [Full Text] [Related]
2. [IgE mediated anaphylaxis in a patient with systemic mastocytosis]. Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896 [TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib. Kudlaty E; Perez M; Stein BL; Bochner BS; Kuang FL J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2534-2536. PubMed ID: 33677080 [No Abstract] [Full Text] [Related]
4. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ; J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094 [TBL] [Abstract][Full Text] [Related]
6. Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients. Vos BJPR; van Anrooij B; van Doormaal JJ; Dubois AEJ; Oude Elberink JNG J Allergy Clin Immunol Pract; 2017; 5(5):1264-1271. PubMed ID: 28499778 [TBL] [Abstract][Full Text] [Related]
7. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization. Hutten EM; Roeloffzen WW; Lambeck AJ; van den Born-Bondt T; Oude Elberink HN; van de Ven AAJ J Investig Allergol Clin Immunol; 2024 Jun; 34(3):214-216. PubMed ID: 38888584 [No Abstract] [Full Text] [Related]
8. Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases. Prieto-García A; Álvarez-Perea A; Matito A; Sánchez-Muñoz L; Morgado JM; Escribano L; Álvarez-Twose I J Allergy Clin Immunol Pract; 2015; 3(3):456-8. PubMed ID: 25687289 [No Abstract] [Full Text] [Related]
9. IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. Burgdorff T; Venemalm L; Vogt T; Landthaler M; Stolz W Ann Allergy Asthma Immunol; 2002 Oct; 89(4):425-8. PubMed ID: 12392389 [TBL] [Abstract][Full Text] [Related]
10. Management of Mastocytosis in Pregnancy: A Review. Lei D; Akin C; Kovalszki A J Allergy Clin Immunol Pract; 2017; 5(5):1217-1223. PubMed ID: 28739366 [TBL] [Abstract][Full Text] [Related]
11. Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis. Kibsgaard L; Skjold T; Deleuran M; Vestergaard C Acta Derm Venereol; 2014 May; 94(3):363-4. PubMed ID: 24162824 [No Abstract] [Full Text] [Related]
12. Severe immunoglobulin E-mediated anaphylaxis to intravenous methylprednisolone succinate in a patient who tolerated oral methylprednisolone. Koutsostathis N; Vovolis V J Investig Allergol Clin Immunol; 2009; 19(4):330-2. PubMed ID: 19639737 [No Abstract] [Full Text] [Related]
13. Effect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis. Ellingwood SS; Kovalszki A Immunol Allergy Clin North Am; 2023 Nov; 43(4):763-776. PubMed ID: 37758412 [TBL] [Abstract][Full Text] [Related]
14. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637 [TBL] [Abstract][Full Text] [Related]
15. Venom anaphylaxis can mimic other serious conditions and disclose important underlying disease. Kjaer HF; Kristensen T; Mortz CG; Vestergaard H; Møller MB; Bindslev-Jensen C; Broesby-Olsen S Ann Allergy Asthma Immunol; 2018 Mar; 120(3):338-339. PubMed ID: 29508726 [No Abstract] [Full Text] [Related]
16. Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA). Dölle-Bierke S; Siebenhaar F; Burmeister T; Worm M J Allergy Clin Immunol; 2019 Nov; 144(5):1448-1450.e1. PubMed ID: 31415784 [No Abstract] [Full Text] [Related]
17. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Hernandez CL; Lynch DM; Golash AJ; Marquis K; Besz KM; Oxnard G; Rotow J; DeAngelo DJ; Castells M Ann Allergy Asthma Immunol; 2023 Nov; 131(5):668-670. PubMed ID: 37597693 [No Abstract] [Full Text] [Related]